IMPEL NEUROPHARMA INC
IMPEL NEUROPHARMA INC (IMPL) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 52 transactions totaling $53.3M, demonstrating a bullish sentiment with $53.2M in net insider flow. The most recent transaction on Dec 19, 2023 involved a sale of 208,657 shares valued at $16.7K.
IMPL Insider Activity Summary
Who Is Buying IMPL Stock?
No significant insider buying has been recorded for IMPL in the recent period.
Who Is Selling IMPL Stock?
No significant insider selling has been recorded for IMPL in the recent period.
Is IMPEL NEUROPHARMA INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IMPL is bullish with an Insider Alignment Score of 100/100 and a net flow of $53.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IMPL Frequently Asked Questions
Understanding IMPL Insider Activity
Insider trading at IMPEL NEUROPHARMA INC (IMPL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading IMPL stock, having executed 52 transactions in the past 90 days. The most active insider is Henry R. Kravis (Executive), who has made 3 transactions totaling $18.1M.
Related Tools
Track IMPEL NEUROPHARMA INC Insider Activity
Get notified when executives and directors at IMPL file new Form 4 transactions